Transcatheter arterial chemoembolization with doxorubicin eluting beads in the treatment of hepatocellular carcinoma;Quimioembolização transarterial com partículas carregadas com doxorrubicina no tratamento do carcinoma hepatocelular

Acta Medica Portuguesa

Volumn 24, Issue 1, 2011, Pages 29-36

  Sousa, Pedro Filipe ^a   Preto, Ana Sofia ^a   Leão, Daniela ^b   Madureira, António Miguel ^a   Paquete, Joaquim ^a   Costa Maia, J ^a   Vilares Morgado, P ^a  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; RETROSPECTIVE STUDY; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CATHETERIZATION; CHEMOEMBOLIZATION, THERAPEUTIC; DOXORUBICIN; DRUG CARRIERS; FEMALE; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 79953245912     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. MARINHO RT, GIRIA J, MOURA MC: Rising costs and hospital admissions for hepatocellular carcinoma in Portugal (1993-2005). World J Gastroenterol 2007;13:1522-7
2. LLOVET JM, BURROUGHS A, BRUIX J: Hepatocellular carcinoma. Lancet. 2003;362(9399):1907-17
3. KALVA SP, THABET A, WICKY S: Recent advances in transarterial therapy of primary and secundary liver malignancies. Radiographics 2008;28:101-117
4. RAMSEY DE, KERNAGIS LY, SOULEN MC, GESCHWIND JF: Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2002;13(9 pt 2):S211-221
5. LEWIS AL, GONZALEZ MV, LLOYD AW et al: DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 2006;17(2 pt 1):335-342
6. BRUIX J, SHERMAN M, LLOVET JM et al: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-430
7. FORNER A, AYUSO C, VARELA M et al: Evaluation of Tumor Response After Locoregional Therapies in hepatocellular Carcinoma Are Response Evaluation Criteria in Solid Tumors Reliable? Cancer 2009;115:616-623
8. LLOVET JM, BRUIX J: Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37:429-442
9. VOGL TJ, EICHLER K, MALAGARI K: Precision V: A randomized phase II trial of a drug-eluting bead in the treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization. Eur Congress Radiol 2009